Brazil Magnetic Resonance Imaging (MRI) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The brazil magnetic resonance imaging market size was valued at USD 340.31 million in 2025 and is estimated to grow from USD 357.5 million in 2026 to reach USD 457.35 million by 2031, at a CAGR of 5.05% during the forecast period (2026-2031). This report is Segmented by Architecture (Closed MRI Systems and Open MRI Systems), Field Strength (Low-Field < 1. 0 T, and More), Application (Oncology, Neurology, and More), End User (Hospitals, Diagnostic Imaging Centers, and Ambulatory Surgical Centers). The Market Forecasts are Provided in Terms of Value (USD).

Brazil Magnetic Resonance Imaging (MRI) Market Trends and Insights

Rising Burden of Chronic Diseases

Stroke, dementia, and cancer cases are mounting as Brazil’s population ages, so serial MRI for staging, follow-up, and treatment response is routine. Neurology already accounts for one-third of Brazil Magnetic Resonance Imaging (MRI) market demand, and oncology needs are accelerating as breast and prostate protocols expand in private centers. Cardiology imaging adds incremental volume because tertiary clinics now request functional data beyond angiography. The shift from episodic care toward chronic disease management keeps repeat-scan volumes high, reinforcing closed high-field systems for lesion detection and multiparametric exams. As chronic diseases cluster in the Southeast’s dense urban areas, diagnostic chains prioritize sites near oncology and neurology reference hospitals.

Expanding Private Health Insurance Coverage

Roughly 25% of Brazilians hold private health plans, and those beneficiaries undergo 179 MRI exams per 1,000 covered lives each year, more than double OECD norms. Rede D'Or, Fleury, and DASA extend their branches into secondary cities to capture this demand, creating a two-tier model in which advanced modalities remain in private hands. ANS rules mandate baseline MRI reimbursement for specified indications, providing providers with predictable revenue streams, yet premium caps constrain insurers’ margins and may curb equipment replacement cycles if membership growth plateaus. Still, large chains leverage volume contracts to negotiate discounts, enabling faster payback on new 3.0 Tesla or AI-enabled units.

High Capital and Maintenance Costs of MRI Systems

A new 1.5 Tesla scanner costs USD 1.0-1.5 million, and 3.0 Tesla models reach USD 3.0 million. Annual service contracts consume up to 12% of the purchase price, while helium refills can add USD 40,000 per year. Import taxes can lift landed prices 30-50%, even after partial relief from the ex-tarifário regime. Private groups dilute costs across large patient volumes, but public hospitals with lower throughput find return-on-investment unattractive, reinforcing the urban-private concentration of equipment[3].

Other drivers and restraints analyzed in the detailed report include:

• Technological Advancements in High-Field and Helium-Free MRI
• Government Investments in Public Hospital Infrastructure
• Low Public Reimbursement Rates Under SUS

Segment Analysis

Closed units held 70.43% of 2025 revenue, underpinning the largest slice of the Brazil Magnetic Resonance Imaging (MRI) market. Image quality remains non-negotiable for neurology and oncology exams, keeping closed 1.5 Tesla and 3.0 Tesla models central to routine practice. Open designs, generally at 1.0 Tesla, expand at 7.54% annually because orthopedic, bariatric, and pediatric scans benefit from wider bores that reduce anxiety and accommodate larger body types. Diagnostic groups in São Paulo mix fleet types, pairing a 3.0 Tesla closed system with an open unit to balance throughput and comfort. Manufacturers respond by offering wide-bore hybrids such as Siemens Free.Max that merge patient access with field strength, blurring historical quality gaps.

Open units rarely match the spatial resolution of closed magnets, yet clinical protocols like musculoskeletal extremity imaging tolerate lower signal noise in exchange for positioning flexibility. Ambulatory centers exploit this trade-off to differentiate service lines while maintaining acceptable reimbursement levels. As AI accelerates reconstruction speed, the performance gulf narrows, further lifting open-system appeal for non-critical exams. Procurement choices therefore hinge on local case-mix and space constraints rather than on a simple quality hierarchy.

High-field 1.0-3.0 Tesla equipment captured 57.43% of 2025 spending and anchors day-to-day clinical throughput, accounting for the core of the Brazil Magnetic Resonance Imaging (MRI) market size. Lower-field portable devices remain niche, serving ICU and rural outreach. Ultra-high-field scanners above 3.0 Tesla expand 7.12% each year, driven by São Paulo universities that pursue advanced neuroimaging and spectroscopy. Sealed magnets limit helium needs and make 3.0 Tesla adoption feasible even in midsize private hospitals. Hyperfine’s 0.064 Tesla Swoop targets intensive-care beds, but uptake depends on SUS reimbursement inclusion.

Academic hospitals embrace 7.0 Tesla units for research, yet budgets and infrastructure requirements cap volumes. The 1.5 Tesla band persists as the default choice for public tenders, balancing cost and coverage of approved protocols. As AI upgrades shorten scan times, 3.0 Tesla productivity rises, unlocking economic justification in centers with heavy oncology or cardiac caseloads. Equipment suppliers therefore segment offerings: workhorse 1.5 Tesla for public bids, productivity-driven 3.0 Tesla for high-volume private hubs, and 7.0 Tesla flagship systems for prestige research programs.

Complete Report Scope:

• By Architecture
  • Closed MRI Systems
  • Open MRI Systems
• By Field Strength
  • Low-Field (< 1.0 T)
  • High-Field (1.0 - 3.0 T)
  • Very High / Ultra-High (> 3.0 T)
• By Application
  • Oncology
  • Neurology
  • Cardiology
  • Gastroenterology
  • Musculoskeletal
  • Other Applications
• By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

List of Companies Covered in this Report:

• Allotech Diagnósticos
• Canon Inc. (Canon Medical Systems)
• EMRAD Equipamentos Médicos
• Esaote
• Fujifilm Holdings Corp.
• GE Healthcare
• Hitachi
• Hyperfine
• Imex Medical Group Do Brasil
• Koninklijke Philips
• MedImagem Serviços Médicos
• Neusoft Medical Systems
• Samsung Electronics
• Siemens Healthineers
• Time Medical Systems
• United Imaging Healthcare

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support